Gedeon Richter PLC (0QFP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Gedeon Richter PLC (0QFP) has a cash flow conversion efficiency ratio of 0.050x as of September 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (£42.97 Billion ≈ $57.71 Billion USD) by net assets (£864.05 Billion ≈ $1.16 Trillion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Gedeon Richter PLC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Gedeon Richter PLC - Cash Flow Conversion Efficiency Trend (2016–2020)
This chart illustrates how Gedeon Richter PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Gedeon Richter PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Gedeon Richter PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ktcs corporation
KO:058850
|
-0.054x |
|
iBio, Inc. Common Stock
NASDAQ:IBIO
|
-0.093x |
|
Barksdale Resources Corp
V:BRO
|
-0.017x |
|
Cingulate Inc
NASDAQ:CING
|
-1.434x |
|
Mercor S.A.
WAR:MCR
|
-0.262x |
|
Remed Co.Ltd
KQ:302550
|
0.006x |
|
Export Packing
KO:002200
|
0.002x |
|
Haulotte Group SA
PA:PIG
|
0.029x |
Annual Cash Flow Conversion Efficiency for Gedeon Richter PLC (2016–2020)
The table below shows the annual cash flow conversion efficiency of Gedeon Richter PLC from 2016 to 2020. For the full company profile with market capitalisation and key ratios, see Gedeon Richter PLC market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-12-31 | £806.96 Billion ≈ $1.08 Trillion |
£133.52 Billion ≈ $179.31 Billion |
0.165x | +20.96% |
| 2019-12-31 | £717.98 Billion ≈ $964.18 Billion |
£98.21 Billion ≈ $131.89 Billion |
0.137x | -7.27% |
| 2018-12-31 | £680.18 Billion ≈ $913.43 Billion |
£100.34 Billion ≈ $134.75 Billion |
0.148x | +16.14% |
| 2017-12-31 | £659.33 Billion ≈ $885.42 Billion |
£83.75 Billion ≈ $112.46 Billion |
0.127x | +11.24% |
| 2016-12-31 | £678.00 Billion ≈ $910.49 Billion |
£77.42 Billion ≈ $103.97 Billion |
0.114x | -- |
About Gedeon Richter PLC
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chron… Read more